References

  1. Apelqvist J, Bakker K, Van Houtum WH, Schaper NC, et al. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot.Diabetes Metab Res Rev. 2008 May-Jun; 24(Suppl 1):S181-7. PubMed | Google Scholar

  2. Schaper NC, Apelqvist J, Bakker K. The international consensus and practical guidelines on the management and prevention of the diabetic foot. CurrDiab Rep. 2003 Dec; 3(6):475-9. PubMed | Google Scholar

  3. Société de Pathologie Infectieuse de Langue Française. Prise en charge du pied diabétique infecté. Med Mal Infect. 2007 Jan; 37(1):26-50. PubMed | Google Scholar

  4. Senneville E. Infection et pied diabétique. Rev Med Interne. 2008 Sep; 29(Suppl2):S243-8. PubMed | Google Scholar

  5. Loan CA, Legout L, Assal M, Rohner P, et al.Infections sévères à Streptococcus agalactiae du pied diabétique: Rôle délétère du Streptococcus agalactiae? Presse Med. 2005 Apr; 34(7):491-4. PubMed | Google Scholar

  6. Sotto A, Lemaire X, Jourdan N, BouzigesN, et al. Activité in vitro de l?értapénème vis-à-vis de souches bactériennes isolées de plaies infectées du pied chez des patients diabétiques. Med Mal Infect. 2008 Mar; 38(3):146-52. PubMed | Google Scholar

  7. Lipsky BA, Armstrong DG, Citron DM, Tice AD, et al. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet. 2005 Nov 12; 366(9498):1695-703. PubMed | Google Scholar

  8. Lipsky BA, Giordano P, Choudhri S, Song J. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. J Antimicrob Chemother. 2007 Aug; 60(2):370-6. PubMed | Google Scholar

  9. Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996 Jul-Aug; 35(4):280-3. PubMed | Google Scholar

  10. Lipsky BA, Berendt AR, Cornia PB, Pile JC, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 Jun;54(12):e132-73. PubMed | Google Scholar

  11. O'Meara S, Nelson EA, Golder S, Dalton JE, et al. Systematic review of methods to diagnose infection in foot ulcers in diabetes. Diabet Med. 2006 Apr; 23(4):341-7. PubMed | Google Scholar

  12. Johnson S, Lebahn F, Peterson LR, Gerding DN. Use of an anaerobic collection and transport swab device to recover anaerobic bacteria from infected foot ulcers in diabetics. Clin Infect Dis. 1995 Jun; 20 (Suppl 2):S289-90. PubMed | Google Scholar

  13. Gerding DN. Foot infections in diabetic patients: the role of anaerobes.Clin Infect Dis. 1995 Jun; 20(Suppl 2):S283-8. PubMed | Google Scholar

  14. Hunt JA. Foot infections in diabetes are rarely due to a single microorganism.Diabet Med. 1992 Oct; 9(8):749-52. PubMed | Google Scholar

  15. Lipsky BA, Berendt AR, Deery HG, Embil JM, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004 Oct;39(7):885-910. PubMed | Google Scholar

  16. Lipsky BA, Sheehan P, Armstrong DG, Tice AD, et al. Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. Int Wound J. 2007 Mar; 4(1):30-8. PubMed | Google Scholar

  17. Tentolouris N, Jude EB, Smirnof I, Knowles EA, et al. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med. 1999 Sep; 16(9):767-71. PubMed | Google Scholar

  18. Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.Diabet Med. 2004 Jul;21(7):710-5. PubMed | Google Scholar

  19. Bessman AN, Geiger PJ, Canawati H. Prevalence of Corynebacteria in diabetic foot infections. Diabetes care. 1992 Nov; 15(11):1531-3. PubMed | Google Scholar

  20. Couret G, Desbiez F, Thieblot P, Tauveron I, et al. Emergence des infections monomicrobiennes à staphylocoque doré méticilline-résistant dans les ostéites du pied diabétique (étude rétrospective de 48 cas). Presse Med. 2007 Jun;36(6 Pt 1):851-8. PubMed | Google Scholar

  21. Kandemir O, Akbay E, Sahin E, Milcan A, et al. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J Infect. 2007 May; 54(5):439-45. PubMed | Google Scholar

  22. Lipsky BA. Diabetic foot infections: microbiology made modern? Array of hope. Diabetes care. 2007 Aug; 30(8):2171-2. PubMed | Google Scholar

  23. Edmonds M, Foster A. The use of antibiotics in the diabetic foot. Am J Surg. 2004 May;187(5A):25S-8S. PubMed | Google Scholar

  24. Lipsky BA, Berendt AR. Principles and practice of antibiotic therapy of diabetic foot infections. Diabetes Metab Res Rev. 2000 Sep-Oct; 16(Suppl 1):S42-6. PubMed | Google Scholar

  25. Shojaiefard A, Khorgami Z, Mohajeri-Tehrani MR, Larijani B. Large and deep diabetic heel ulcers need not lead to amputation. Foot Ankle Int. 2013 Feb; 34(2):215-21. PubMed | Google Scholar

  26. Van Battum P, Schaper N, Prompers L, Apelqvist J, et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation.Diabet Med. 2011 Feb; 28(2):199-205. PubMed | Google Scholar

  27. Weledji EP, Fokam P. Treatment of the diabetic foot - to amputate or not? BMC Surg. 2014; 14:83. PubMed | Google Scholar

  28. Rayman G, Krishnan ST, Baker NR, Wareham AM, et al. Are we underestimating diabetes-related lower-extremity amputation rates? Results and benefits of the first prospective study. Diabetes care. 2004 Aug; 27(8):1892-.. PubMed | Google Scholar

  29. Richard JL, Lavigne JP, Got I, Hartemann A, et al. Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study. Diabetes Metab. 2011 Jun;37(3):208-15. PubMed | Google Scholar